Immunome Inc. (IMNM) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $48.84M | -17.3% |
| 2024 | $59.08M | +106.1% |
| 2023 | $28.66M | +287.6% |
| 2022 | $7.39M | -24.1% |
| 2021 | $9.74M | +206.3% |
| 2020 | $3.18M | +77.1% |
| 2019 | $1.80M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $48.84M | -17.3% |
| 2024 | $59.08M | +106.1% |
| 2023 | $28.66M | +287.6% |
| 2022 | $7.39M | -24.1% |
| 2021 | $9.74M | +206.3% |
| 2020 | $3.18M | +77.1% |
| 2019 | $1.80M | — |